COL6A3 Gene Bethlem myopathy type 1 Genetic Test
Welcome to DNA Labs UAE, where we offer the COL6A3 Gene Bethlem myopathy type 1 Genetic Test.
Test Details
The COL6A3 gene is associated with Bethlem myopathy type 1, a rare genetic disorder that affects the muscles and joints. Our Next-Generation Sequencing (NGS) genetic testing utilizes advanced DNA analysis to identify mutations or variations in the COL6A3 gene that may be responsible for causing Bethlem myopathy type 1. This type of testing can help diagnose the condition, determine its severity, and guide treatment options. It may also be used for genetic counseling and to identify family members who may be at risk for inheriting the condition.
Test Components
- COL6A3 Gene Bethlem myopathy type 1 Genetic Test
Price
AED 4400.0
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
It is important to provide the clinical history of the patient who is going for the COL6A3 Gene Bethlem myopathy type 1 NGS Genetic DNA Test. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with COL6A3 Gene Bethlem myopathy type 1.
Test Name | COL6A3 Gene Bethlem myopathy type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for COL6A3 Gene Bethlem myopathy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with COL6A3 Gene Bethlem myopathy type 1 |
Test Details | The COL6A3 gene is associated with Bethlem myopathy type 1, a rare genetic disorder that affects the muscles and joints. NGS (Next-Generation Sequencing) genetic testing is a type of DNA analysis that can identify mutations or variations in the COL6A3 gene that may be responsible for causing Bethlem myopathy type 1. This type of testing can help diagnose the condition, determine its severity, and guide treatment options. It may also be used for genetic counseling and to identify family members who may be at risk for inheriting the condition. |